Split Thickness Donor Site Healing With MIST Study
A Prospective, Randomized, Controlled Pilot Study of the MIST Therapy System for the Treatment of Split Thickness Donor Sites
1 other identifier
interventional
32
1 country
1
Brief Summary
Subjects requiring skin grafting due to burns, trauma, or chronic venous ulcers with split thickness donor sites expected to be between 20 and 200 square cm will be consecutively screened for study eligibility. This study is a prospective, randomized, controlled trial evaluating effect of MIST Therapy on the healing of split thickness skin graft donor sites compared to standard care. Subjects meeting all eligibility criteria and providing appropriate written informed consent will be enrolled for study participation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2010
CompletedFirst Posted
Study publicly available on registry
October 5, 2010
CompletedStudy Start
First participant enrolled
February 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2014
CompletedResults Posted
Study results publicly available
December 19, 2014
CompletedDecember 19, 2014
December 1, 2014
1.4 years
October 4, 2010
December 11, 2014
December 18, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Rate of Wound Healing
The primary endpoint is an average of the group for each participant's donor site wound closure time, defined as days to absence of drainage from the date of the initial donor site harvest procedure.
Days to absence of drainage from the initial donor site harvest procedure
Secondary Outcomes (4)
Time to Full Epithelialization
Days to full epithelialization
Numeric Pain Score
5 weeks
Numeric Itching Score
5 weeks
Donor Site Recidivism Rate
6 weeks
Study Arms (2)
MIST Therapy in conjunction with SOC
EXPERIMENTALLow-frequency, non-contact ultrasound administered in conjunction with standard of care treatment
Control arm
ACTIVE COMPARATORStandard of care treatment
Interventions
Low-frequency, non-contact ultrasound therapy provided in conjunction with standard of care treatment on a daily basis for 5 days.
Standard of care provided per site-specific protocol
Eligibility Criteria
You may qualify if:
- Male or female subject of any race and at least 18 years old
- Subject requires skin grafting
- Subject's wound must be between 20 cm2 and 200 cm2
- Subject's wound presents with no clinical signs of acute infection
- Subject has ahd no prior MIST Therapy to the enrolled wound
- Subject or subject's legally authorized representative understands the nature of the procedure(s) and provides written informed consent prior to study enrollment
- Subject is willing and able to comply with all specified care and visit requirements
- Women of childbearing potential must not be pregnant or lactating, and must be using adequate and accepted contraceptive methods
- Subject has a reasonable expectation of completing the study
You may not qualify if:
- Subject's condition requires the use of topical antibiotics at the time of study enrollment
- Subject's wound would require ultrasound near an electronic implant or prosthesis, e.g., near or over the heart, or over the thoracic area if the subject is using a cardiac pacemaker
- Subject is known to be suffering from a disorder or other situation that the subject or investigator feels would interfere with compliance or other study requirements
- Subject is currently enrolled or has been enrolled in the last 30 days in another investigational device or drug trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tampa General Hospital
Tampa, Florida, 33606, United States
Related Publications (2)
Sinha S, Gabriel VA, Arora RK, Shin W, Scott J, Bharadia SK, Verly M, Rahmani WM, Nickerson DA, Fraulin FO, Chatterjee P, Ahuja RB, Biernaskie JA. Interventions for postburn pruritus. Cochrane Database Syst Rev. 2024 Jun 5;6(6):CD013468. doi: 10.1002/14651858.CD013468.pub2.
PMID: 38837237DERIVEDPrather JL, Tummel EK, Patel AB, Smith DJ, Gould LJ. Prospective Randomized Controlled Trial Comparing the Effects of Noncontact Low-Frequency Ultrasound with Standard Care in Healing Split-Thickness Donor Sites. J Am Coll Surg. 2015 Aug;221(2):309-18. doi: 10.1016/j.jamcollsurg.2015.02.031. Epub 2015 Mar 14.
PMID: 25868409DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Participants were not blinded to study treatment.
Results Point of Contact
- Title
- Dr. Lisa Gould
- Organization
- University South Florida
Study Officials
- PRINCIPAL INVESTIGATOR
Lisa J Gould, M.D.,Ph.D
James A. Haley Veterans Hospital
- PRINCIPAL INVESTIGATOR
David Smith, MD
University South Florida
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 4, 2010
First Posted
October 5, 2010
Study Start
February 1, 2012
Primary Completion
July 1, 2013
Study Completion
July 1, 2014
Last Updated
December 19, 2014
Results First Posted
December 19, 2014
Record last verified: 2014-12